Paul Alloway

Paul Alloway discloses dealings in Q32 Bio Inc. to SEC (Form 4). Over a trading history stretching from 1 January 2023 to 25 March 2024, the count stands at 7 filings.

Sales make up the whole of the open-market record (4 sales, €29k). Outside the open market, there are 3 option exercises. So far in 2024, the count stands at no purchases and 2 sales.

The newest entry dates from 23 April 2024: an open-market sale of €6,003, in Q32 Bio Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.